Vitamin
E Effective Treatment for Abnormal Movement Disorder
Healthnotes Newswire (March 11, 2004)—People with schizophrenia
or related mental disorder who develop involuntary movements of
the arms, legs, or mouth (called tardive dyskinesia [TD]) after
taking anti-psychotic medications may experience a reduction in
these movements by taking supplemental vitamin E, reports the
Journal of Clinical Psychopharmacology (2004;24:83–6). This
is encouraging news for the millions of people around the world
who suffer from this condition.
People with TD suffer from repetitive and uncontrollable
movements—puckering of the lips or mouth, writhing of the
arms or legs—that can interfere greatly with their quality
of life. TD is most often associated with long-term use of anti-psychotic
medications, such as chlorpromazine (Thorazine®), thioridazine
(Mellaril®), or trifluoperazine (Stelazine®). It is believed
that these medications increase free radicals in the body, which
in turn injure the neurological system. Vitamin E is a potent
antioxidant and may help protect the body against free-radical
damage.
In the new study, 41 Chinese adults with schizophrenia
between the ages of 30 and 60 years were randomly assigned to
receive 1,200 IU per day of vitamin E or placebo for 12 weeks.
The degree of TD was measured using the Abnormal Involuntary Movement
Scale (AIMS) initially and after 6 and 12 weeks of treatment.
Blood levels of superoxide dismutase (SOD), a critical enzyme
involved with elimination of free radicals, were measured before
and after treatment. People with TD have been shown to have lower
levels of SOD than those without TD.
The degree of TD decreased by 46% in those taking
vitamin E, compared with only 4% in those taking placebo. SOD
levels increased by 30% in the vitamin E treatment group, while
no significant increase in SOD was observed in the placebo group.
In addition to the reduction of TD with vitamin E treatment, these
findings suggest vitamin E also boosts SOD levels in the blood,
which may offer additional protection against free-radical damage.
Studies suggest that other nutrients may be useful
in treating TD. Choline, lecithin, and evening primrose oil may
reduce the severity of TD, although large amounts are often necessary
to achieve desirable results. One group of researchers treated
approximately 11,000 schizophrenics with a megavitamin regimen
that included vitamin C (up to 4 grams per day); vitamin B3, either
as niacin or niacinamide (up to 4 grams per day); vitamin B6 (up
to 800 mg per day); and vitamin E (up to 1,200 IU per day). During
that time, not a single new case of TD was seen, even though many
of the people were taking anti-psychotic drugs. Further research
is needed to determine which nutrients or combinations of nutrients
were most important for preventing TD. The amounts of niacinamide
and vitamin B6 used in this research may cause significant side
effects and should only be taken under the supervision of a physician.